论文部分内容阅读
目的:探究长春西汀治疗急性冠脉综合征合并高血压的疗效。方法:选择2015年10月~2016年10月我院收治的急性冠脉综合征合并高血压患者60例作为研究对象,将患者随机均匀分成两组,其中对照组予以常规治疗,观察组在此前提下联合长春西汀静脉点滴治疗,比对两组患者心绞痛发作情况、血压指标。结果:经过治疗后,观察组心绞痛发作情况与对照组相比,效果明显,数据有统计学意义(P<0.05);但两组患者血压指标无显著差异(P>0.05)。结论:治疗急性冠脉综合征合并高血压患者时加入长春西汀,能够缩短患者心绞痛发作时间、降低心绞痛发作机率,值得推广。
Objective: To investigate the efficacy of Vinpocetine in the treatment of acute coronary syndrome complicated with hypertension. Methods: From October 2015 to October 2016, 60 patients with acute coronary syndrome and hypertension in our hospital were selected as the research object. The patients were randomly divided into two groups randomly. The control group received routine treatment and the observation group Under the premise of the combination of vinpocetine intravenous drip treatment, compared with two groups of patients with angina pectoris, blood pressure. Results: After treatment, angina pectoris in the observation group was significantly better than that in the control group (P <0.05). There was no significant difference in blood pressure between the two groups (P> 0.05). Conclusion: Adding Vinpocetine to patients with acute coronary syndrome complicated with hypertension can shorten the angina pectoris time and reduce the incidence of angina pectoris, which is worth promoting.